SCHEDULE: First Light Asset Management Boosts Organogenesis Stake

Sentiment:

Beneficial Ownership Report


First Light Asset Management and Mathew P. Arens report increased beneficial ownership in Organogenesis Holdings, Inc., now holding 6.55% of common stock.

Summary

  • First Light Asset Management, LLC and Mathew P. Arens have jointly filed a Schedule 13G, reporting their beneficial ownership in Organogenesis Holdings, Inc. common stock.
  • First Light Asset Management, LLC beneficially owns 8,061,404 shares, representing 6.35% of the class, with shared voting and dispositive power over these shares.
  • Mathew P. Arens beneficially owns a total of 8,309,404 shares, representing 6.55% of the class.
  • Mr. Arens holds 231,000 shares with sole voting and dispositive power, and shares control over 8,078,404 shares, which includes shares held by First Light Asset Management, LLC, where he is the managing member and majority owner.
  • The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual report of beneficial ownership, which is neutral in tone. The increased ownership by an investment adviser can be viewed positively by the market, but the filing itself does not contain performance or forward-looking statements to indicate a strong positive or negative sentiment.

Positives

  • Increased institutional ownership by First Light Asset Management and its principal, Mathew P. Arens, signals confidence in Organogenesis Holdings, Inc.

Future Outlook

NA

Management Comments

  • "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."

Industry Context

NA

Stakeholder Impact

  • Shareholders may view the increased beneficial ownership by an investment adviser and its principal as a positive signal, potentially indicating institutional confidence in the company's future prospects.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement
08/14/2025Date of signing of the Schedule 13G filing

Keywords

Organogenesis Holdings, Common Stock, Beneficial Ownership, SEC Filing, Schedule 13G, First Light Asset Management, Mathew P. Arens, Investment Adviser

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.